1992
DOI: 10.1111/j.1651-2227.1992.tb12120.x
|View full text |Cite
|
Sign up to set email alerts
|

Hydrops fetalis associated with Ureaplasma urealyticum

Abstract: A hydroptic newborn was born at 32 weeks' gestation and at the age of 14 h died of post-asphyxial syndrome. Immunologic causes of hydrops fetalis were excluded, as were anomalies and chromosomal aberrations. Ureaplasma urealyticum was isolated in bronchial secretions, lung tissue and brain tissue of the newborn. Our findings suggest that U. urealyticum infection should be considered in the differential diagnosis of hydrops fetalis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1995
1995
2009
2009

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…A case of fatal nonimmune hydrops fetalis was reported in which Ureaplasma spp. was isolated in bronchial secretions, lung tissue and brain tissue, suggesting these organisms should be considered in the differential diagnosis of hydrops fetalis which may in some instances be caused by infections (205).…”
Section: Other Infectionsmentioning
confidence: 99%
“…A case of fatal nonimmune hydrops fetalis was reported in which Ureaplasma spp. was isolated in bronchial secretions, lung tissue and brain tissue, suggesting these organisms should be considered in the differential diagnosis of hydrops fetalis which may in some instances be caused by infections (205).…”
Section: Other Infectionsmentioning
confidence: 99%
“…These organisms are associated with chorioamnionitis [14] and premature delivery [11] and are frequently transmitted from mothers to their infants either in utero or during delivery [20]. The colonization of the respiratory tract in newborn or premature infants has been associated with various diseases including osteomyelitis [10], pneumonia [3], persistent pulmonary hypertension [26], chronic infection of the central nervous system [18,25] and bronchopulmonary dysplasia (BPD) [4,15,21,27]. Most studies were conducted prior to the introduction of surfactant for treating hyaline membrane disease or involved only small numbers of patients.…”
Section: Introductionmentioning
confidence: 99%